Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Biostar Expects 2010 Revenues to Climb Higher

publication date: Mar 1, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Biostar Pharmaceuticals expects 2010 revenues of about $70 million and net income of $17 million, excluding non-cash charges. The company is on track to report 2009 revenues of around $52 million, which means the 2010 guidance represents an increase of 35%. About 70% of Biostar’s revenues are generated by Xin Aoxing Oleanolic Acid Capsules, an over-the-counter TCM treatment for hepatitis B. More details...

Stock Symbol: (OTCBB: BSPM)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners